Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Rise 0.5% Tuesday; Rio Tinto, Equinor Among Leaders

06/01/2021 | 11:18am EDT


© MT Newswires 2021
All news about ERYTECH PHARMA S.A.
07/30Top Midday Gainers
MT
07/30ERYTECH PHARMA S A : ▪Fast Track designation for eryaspase underscores the..
PU
07/30European ADRs Drop Nearly 0.5% as Miners, Drillers Lag
MT
07/30FDA Grants Fast Track Designation for Eryaspase in Hypersensitive All of Eryt..
CI
07/30SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Friday
MT
07/30Wall Street Sees Weak Open, Amazon's Downbeat Revenue Outlook Weighs Heavy on..
MT
07/30SECTOR UPDATE : Health Care
MT
07/30Top Premarket Gainers
MT
07/30ERYTECH PHARMA GETS FDA FAST TRACK D : Shares Jump
MT
07/30ERYTECH PHARMA S A : Wins US FDA's Fast Track For Acute Lymphocytic Leukemia Tre..
MT
More news
Financials
Sales 2021 8,21 M 9,75 M 9,75 M
Net income 2021 -60,0 M -71,3 M -71,3 M
Net Debt 2021 16,1 M 19,1 M 19,1 M
P/E ratio 2021 -1,60x
Yield 2021 -
Capitalization 165 M 196 M 196 M
EV / Sales 2021 22,1x
EV / Sales 2022 5,80x
Nbr of Employees 206
Free-Float 88,9%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 6,25 €
Average target price 14,50 €
Spread / Average Target 132%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-12.10%196
GILEAD SCIENCES, INC.19.86%85 648
BIONTECH SE302.78%79 303
WUXI APPTEC CO., LTD.33.61%59 516
REGENERON PHARMACEUTICALS18.94%59 505
VERTEX PHARMACEUTICALS-14.71%52 296